Source: EP Vantage (originally posted 30 Sept 2011) Improved Gardasil? As the global debate about the cost effectiveness – and in some places ethics – of human papilloma virus (HPV) vaccines rumbles on, Merck & Co has been quietly working away on a 21,000 patient phase III program for an improved version of its blockbuster vaccine Gardasil. Relatively […]
Merck Must Defend Securities-Fraud Claims Over Risks of Vioxx, Judge Rules
Bloomberg By David Voreacos – Aug 10, 2011 1:54 PM MT Merck & Co. must defend a lawsuit claiming it violated securities laws by downplaying the cardiovascular risks of its Vioxx painkiller before the company pulled the drug from the market in 2004, a judge ruled. Merck, the second-biggest U.S. drugmaker, withdrew Vioxx after a […]
Merck gets DOJ subpoena on drug marketing
The Wall Street Journal Market Watch Aug. 8, 2011, 11:30 a.m. EDT By Peter Loftus The U.S. Justice Department has issued a subpoena to Merck & Co. MRK +0.97% as part of a criminal investigation into the marketing of certain drugs, Merck said Monday. The drugs are Temodar, which treats brain tumors; hepatitis C treatment […]
Merck gets subpoena tied to marketing of 3 drugs
Yahoo Finance On Monday August 8, 2011, 9:50 am EDT NEW YORK (Reuters) – The Department of Justice has issued Merck & Co (NYSE:MRK – News) a subpoena seeking information about the drugmaker’s marketing of three drugs acquired in its 2009 merger with Schering-Plough Corp. The subpoena, which Merck disclosed in its quarterly securities filing, […]
Is That Plastic Shrink Wrap In Your Merck Vaccine?
Pharmalot By Ed Silverman // July 29th, 2011 // 12:13 pm As if Merck does not have enough problems with vaccine production, the drugmaker apparently distributed charred bits of plastic shrink wrap in vials of various vaccines – including Gardasil for preventing HPV infection, Varivax for chicken pox, Pneumovax for pneumococcal disease, Zostavax for shingles […]
- 1
- 2
- 3
- 4
- Next Page »
